LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: High Seroconversion Rate Against Severe Acute Respiratory Syndrome Coronavirus 2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.

Ruan, Wenly / Nguyen, Huyen / Wyatt, Allyson / Ihekweazu, Faith / Vartabedian, Bryan S / Karam, Lina / Walsh, Seema / Kellermayer, Richard

Journal of pediatric gastroenterology and nutrition

2021  Volume 73, Issue 3, Page(s) 363–366

Abstract: ... where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed ... inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients ... rates of COVID-19 seroconversion occurred in immunosuppressed and symptomatic PIBD patients. More ...

Abstract Abstract: Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal reverse transcriptase polymerase chain reaction were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms, SARS-CoV-2 testing date, and SARS-CoV-2 immunoglobulin G (IgG) antibody testing date and result were examined. Of 14 SARS-CoV-2 positive PIBD patients, 12 were tested for qualitative anti-SARS-CoV-2 IgG (seven with transient COVID-19 symptoms, five asymptomatic). All symptomatic (7/7) and 60% of asymptomatic (3/5) patients seroconverted. No patients required hospitalization attributed to COVID-19.High rates of COVID-19 seroconversion occurred in immunosuppressed and symptomatic PIBD patients. More research to evaluate the significance of COVID-19 seroconversion is needed.
MeSH term(s) Antibodies, Viral ; COVID-19 ; COVID-19 Testing ; Child ; Humans ; Inflammatory Bowel Diseases ; SARS-CoV-2 ; Seroconversion
Chemical Substances Antibodies, Viral
Language English
Publishing date 2021-06-22
Publishing country United States
Document type Journal Article
ZDB-ID 603201-1
ISSN 1536-4801 ; 0277-2116
ISSN (online) 1536-4801
ISSN 0277-2116
DOI 10.1097/MPG.0000000000003211
Shelf mark
Zs.A 1728: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top